Skip to main content
TipRanks
Go Ultimate75% OFF

Fermentalg SA (1F6) AI Stock Analysis

0 Followers
DE:1F6

Fermentalg SA

(Frankfurt:1F6)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue ExpansionThe substantial increase in revenue demonstrates meaningful commercial progress and broader market adoption of Fermentalg’s microalgae-based ingredients. Continued top-line growth can improve operating leverage over time, provided the company converts expanding sales into stronger margins and cash generation.
Negative Factors
Persistent UnprofitabilityFermentalg has not yet scaled its revenue base sufficiently to cover its cost structure, despite improved sales and gross margin. Persistent operating and net losses weaken financial resilience, constrain internally funded investment, and make future performance dependent on achieving a meaningful profitability inflection.

Fermentalg SA (1F6) vs. iShares MSCI Germany ETF (EWG)

-30%-20%-10%0%10%20%30%40%50%DE:1F6-15.44%EWG+9.15%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 47.45M
Dividend Yield
―
Average Volume (3M)
866
Price to Earnings (P/E)
-4.7
Beta (1Y)
1.23
Revenue Growth
3.22%
EPS Growth
24.05%
Country
Germany
Employees
62
Sector
Healthcare
Sector Strength
51
Industry
Biotechnology

Fermentalg SA Business Overview & Revenue Model

Company Description

Fermentalg SA, established in 2009 and headquartered in Libourne, France, is an internationally operating company specializing in the research, manufacturing, and sale of functional ingredients sourced from microalgae. These offerings serve various i...

Fermentalg SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:1F6 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:ALPATFR:ALPAT60NeutralEUR 4.52M6.59――10.59%―
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
FR:ALVALFR:ALVAL43NeutralEUR 21.85M-2.09-84.11%―183.47%57.15%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%DE:1F6FR:ALVALFR:ALPATDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:1F6 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:1F6Fermentalg SA0.38-0.07-16.00%
FR:ALVALValbiotis SA0.620.047.13%
FR:ALPATPlant Advanced Technologies SA3.98-4.42-52.62%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.